Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2010 1
2020 1
2023 4
2024 8
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study.
Balestri R, Odorici G, Magnano M, Gisondi P, Bellinato F, Ribero S, Dapavo P, Mastorino L, Burlando M, Cozzani E, Bernardini N, Potenza C, Balato A, Caccavale S, Di Lernia V, Peccerillo F, Megna M, Campanati A, Loconsole F, Mortato E, Trovato E, Mantovani L, Caldarola G, De Simone C, Falco GM, Narcisi A, Alfano A, Galluzzo M, Fico A, Pezzolo E, Prignano F, Di Cesare A, Loi C, Satolli F, Musumeci ML, Ortega R, Errichetti E, Dini V, Michelucci A, Amerio P, Carugno A, Tabanelli M, Conti A, Guarneri C, Bardazzi F, Rech G. Balestri R, et al. Among authors: falco gm. J Eur Acad Dermatol Venereol. 2025 May 29. doi: 10.1111/jdv.20774. Online ahead of print. J Eur Acad Dermatol Venereol. 2025. PMID: 40439441 No abstract available.
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study).
Orsini D, Caldarola G, Dattola A, Campione E, Bernardini N, Frascione P, De Simone C, Richetta AG, Galluzzo M, Skroza N, Assorgi C, Amore E, Falco GM, Gaeta Shumak R, Artosi F, Maretti G, Potenza C, Bianchi L, Pellacani G, Peris K, Bonifati C, Graceffa D. Orsini D, et al. Among authors: falco gm. J Dermatolog Treat. 2024 Dec;35(1):2319304. doi: 10.1080/09546634.2024.2319304. Epub 2024 Feb 27. J Dermatolog Treat. 2024. PMID: 38413097 Free article.
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study.
Avallone G, Maronese CA, Zussino M, Muratori S, Ferrucci SM, Quaglino P, Manni E, Romanelli M, De Simone C, Foti C, Gargiulo L, Maione V, Calzavara-Pinton P, Bardazzi F, Piraccini BM, Antiga E, Rech G, Balestri R, Vezzoli P, Sena P, Esposito M, Fargnoli MC, Termini D, Valtellini L, Satta RR, Vassallo C, Provini A, Di Zenzo G, Campanati A, Caproni M, Cozzani E, Ribero S, Marzano AV; DUO—DUpilumab and Omalizumab in Bullous Pemphigoid Study Group. Avallone G, et al. J Dermatol. 2025 Jun;52(6):983-1000. doi: 10.1111/1346-8138.17742. Epub 2025 Apr 16. J Dermatol. 2025. PMID: 40237419
18 results